{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T11:06:55Z","timestamp":1785323215753,"version":"3.55.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.urolonc.2024.01.002","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T21:36:47Z","timestamp":1709242607000},"page":"117.e17-117.e25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium"],"prefix":"10.1016","volume":"42","author":[{"given":"Ian","family":"Cooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassib","family":"Abou Heidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Wasay","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"St\u00f6ckle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Roupret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Vasdev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derya","family":"Balbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon Ho","family":"Rha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Aboumohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prokar","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Maatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Richstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Wiklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Gaboardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed A.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khurshid","family":"Guru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.urolonc.2024.01.002_bib0001","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis","volume":"21","author":"Yin","year":"2016","journal-title":"Oncologist"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.002_bib0002","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/JU.0000000000001855","article-title":"Pathological downstaging and survival outcomes associated with neoadjuvant chemotherapy for variant histology muscle invasive bladder cancer","volume":"206","author":"Chakiryan","year":"2021","journal-title":"J Urol"},{"issue":"22","key":"10.1016\/j.urolonc.2024.01.002_bib0003","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1002\/cncr.30907","article-title":"Neoadjuvant chemotherapy prior to radical cystectomy for muscle-invasive bladder cancer with variant histology","volume":"123","author":"Vetterlein","year":"2017","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2024.01.002_bib0004","doi-asserted-by":"crossref","first-page":"314","DOI":"10.4103\/0970-1591.134253","article-title":"International radical cystectomy consortium: a way forward","volume":"30","author":"Raza","year":"2014","journal-title":"Indian J Urol"},{"key":"10.1016\/j.urolonc.2024.01.002_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.671969","article-title":"Treatments outcomes in histological variants and non-urothelial bladder cancer: results of a multicenter retrospective study","volume":"11","author":"Epaillard","year":"2021","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.002_bib0006","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/his.13752","article-title":"Variants and new entities of bladder cancer","volume":"74","author":"Lopez-Beltran","year":"2019","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.002_bib0007","first-page":"205","article-title":"Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration","volume":"48","year":"2005","journal-title":"Eur Urol"},{"issue":"16","key":"10.1016\/j.urolonc.2024.01.002_bib0008","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2010.32.3139","article-title":"International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial","volume":"29","author":"Griffiths","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.002_bib0009","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s10147-019-01409-x","article-title":"Squamous cell carcinoma of the bladder: poor response to neoadjuvant chemotherapy","volume":"24","author":"Dotson","year":"2019","journal-title":"Int J Clin Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.002_bib0010","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.juro.2012.11.084","article-title":"Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis","volume":"189","author":"Dayyani","year":"2013","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.002_bib0011","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.euf.2017.06.013","article-title":"The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy","volume":"5","author":"Li","year":"2019","journal-title":"Eur Urol Focus"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.002_bib0012","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.euo.2018.11.003","article-title":"Comparative effectiveness of treatment strategies for squamous cell carcinoma of the bladder","volume":"3","author":"Stensland","year":"2020","journal-title":"Eur Urol Oncol"},{"issue":"6","key":"10.1016\/j.urolonc.2024.01.002_bib0013","doi-asserted-by":"crossref","first-page":"353.e17","DOI":"10.1016\/j.urolonc.2019.01.020","article-title":"The impact of squamous histology on survival in patients with muscle-invasive bladder cancer","volume":"37","author":"Matulay","year":"2019","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.002_bib0014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.eururo.2012.04.020","article-title":"Neoadjuvant chemotherapy in small cell urothelial cancer improves pathologic downstaging and long-term outcomes: results from a retrospective study at the MD Anderson Cancer Center","volume":"64","author":"Lynch","year":"2013","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.002_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/cncr.22756","article-title":"Micropapillary bladder cancer: a review of the University of Texas M. D. Anderson Cancer Center experience with 100 consecutive patients","volume":"110","author":"Kamat","year":"2007","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.urolonc.2024.01.002_bib0016","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1111\/j.1464-410X.2012.11751.x","article-title":"Pathological response to neoadjuvant chemotherapy for muscle-invasive micropapillary bladder cancer","volume":"111","author":"Meeks","year":"2013","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.002_bib0017","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/JU.0000000000001325","article-title":"Pathological and survival outcomes associated with variant histology bladder cancers managed by cystectomy with or without neoadjuvant chemotherapy","volume":"205","author":"Hajiran","year":"2021","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2024.01.002_bib0018","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/j.1464-410X.2010.09900.x","article-title":"Do mixed histological features affect survival benefit from neoadjuvant platinum-based combination chemotherapy in patients with locally advanced bladder cancer? A secondary analysis of Southwest Oncology Group-Directed Intergroup Study (S8710)","volume":"108","author":"Scosyrev","year":"2011","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.002_bib0019","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.urolonc.2019.12.019","article-title":"Pathological downstaging following radical cystectomy for muscle-invasive bladder cancer: Survival outcomes in the setting of neoadjuvant chemotherapy versus transurethral resection only","volume":"38","author":"Cajipe","year":"2020","journal-title":"Urol Oncol"},{"issue":"9","key":"10.1016\/j.urolonc.2024.01.002_bib0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.urolonc.2024.01.002_bib0021","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1007\/s11255-022-03358-3","article-title":"Neoadjuvant chemotherapy for muscle-invasive bladder cancer: does variant histology matter?","volume":"54","author":"Catarino","year":"2022","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.002_bib0022","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.clgc.2015.08.006","article-title":"Clinical outcomes after neoadjuvant chemotherapy and radical cystectomy in the presence of urothelial carcinoma of the bladder with squamous or glandular differentiation","volume":"14","author":"Zargar-Shoshtari","year":"2016","journal-title":"Clinical Genitourinary Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.002_bib0023","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/bju.13678","article-title":"Impact of suboptimal neoadjuvant chemotherapy on peri-operative outcomes and survival after robot-assisted radical cystectomy: a multicentre multinational study","volume":"119","author":"Hinata","year":"2017","journal-title":"BJU Int"},{"issue":"16","key":"10.1016\/j.urolonc.2024.01.002_bib0024","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1200\/JCO.2008.19.0256","article-title":"Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide\/doxorubicin and etoposide\/cisplatin in small-cell urothelial cancer","volume":"27","author":"Siefker-Radtke","year":"2009","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.002_bib0025","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1016\/j.clgc.2021.11.011","article-title":"Impact of variant histology on occult nodal metastasis after neoadjuvant chemotherapy for muscle-invasive bladder cancer: a review of the National Cancer Database","volume":"20","author":"Fu","year":"2022","journal-title":"Clin Genitourin Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2024.01.002_bib0026","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1016\/j.clgc.2015.09.013","article-title":"Predictors of complete pathologic response (pT0) to neoadjuvant chemotherapy in muscle-invasive bladder carcinoma","volume":"14","author":"Pokuri","year":"2016","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"10.1016\/j.urolonc.2024.01.002_bib0027","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3233\/BLC-160066","article-title":"Micropapillary bladder cancer: insights from the National Cancer Database","volume":"2","author":"Sui","year":"2016","journal-title":"Bladder Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2024.01.002_bib0028","first-page":"6690","article-title":"Neoadjuvant chemotherapy in the treatment of muscle invasive bladder cancer with mixed histology","volume":"20","author":"Lin","year":"2013","journal-title":"Can J Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143924000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T03:46:44Z","timestamp":1730864804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143924000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1078143924000024"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.002","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of neoadjuvant chemotherapy for patients with variant histology muscle invasive bladder cancer undergoing robotic cystectomy: Data from the International Robotic Cystectomy Consortium","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2024.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}